MedTrace Logo

Clinical Situations at High Risk of Placenta Accreta / Percreta

NCT02010229 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 674

Last updated 2026-03-10

No results posted yet for this study

Summary

The purpose of this study is to identify what factors -either individual or related to the type of management received- influence the maternal outcomes in pregnant women at high risk for placenta accreta i.e , women with placenta praevia and previous caesarean.

This population-based study conducted in 8 French regions will also provide valid estimation of the incidence of placenta accreta among all parturients and among "at risk "women. Finally, a psychological evaluation of these women up to 1 year after delivery will provide information on the impact of these conditions on women, beyond somatic complications.

Conditions

  • Placenta Accreta / Percreta

Sponsors & Collaborators

  • Inserm U953 (Epidemiological research unit on perinatal health and women's and children's health) Paris, France

    collaborator UNKNOWN

  • University Hospital, Angers

    collaborator OTHER_GOV

  • URC-CIC Paris Descartes Necker Cochin

    collaborator OTHER

  • Assistance Publique - Hôpitaux de Paris

    lead OTHER

Principal Investigators

  • Gilles Kayem, MD, PhD · Louis Mourier University Hospital (APHP), department of gynaecology and obstetrics, Colombes, France

  • Loic Sentilhes, MD, PhD · Angers University Hospital, department of gynaecology and obstetrics, France

  • Catherine Deneux-Tharaux, MD, PhD · INSERM U953, Epidemiological research unit on perinatal health and children's and women's health, Paris, France

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-11-04
Primary Completion
2016-11-30
Completion
2017-08-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02010229 on ClinicalTrials.gov